5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).

Gebbia, V; Maiello, E; Serravezza, G; Giotta, F; Testa, A; Borsellino, N; Pezzella, G; Colucci, G

Gebbia, V; Maiello, E; Serravezza, G; Giotta, F; Testa, A; Borsellino, N; Pezzella, G; Colucci, G.

Affiliation

Gebbia V; Division of Medical Oncology, Centro Catanese di Oncologia, Catania, Italy.

Anticancer Res ; 19(2B): 1407-10, 1999.

Article in En | MEDLINE | ID: mdl-10365114

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Hepatocellular/drug therapy; Liver Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carcinoma, Hepatocellular/pathology; Female; Fluorouracil/administration & dosage; Humans; Hydroxyurea/administration & dosage; Leucovorin/administration & dosage; Leukopenia/chemically induced; Liver Neoplasms/pathology; Male; Middle Aged; Thrombocytopenia/chemically induced; Vomiting/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 1999 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links